Animal models of schizophrenia

Area of Science:

• Neuroscience
• Psychiatry
• Pharmacology

Background:

• Reliable animal models are essential for understanding schizophrenia's neurobiological basis and developing new drugs.
• Current models often focus on positive symptoms, neglecting negative and cognitive deficits resistant to existing treatments.

Purpose of the Study:

• To review existing animal models of schizophrenia based on induction categories.
• To assess the translational relevance of behavioral tasks for evaluating antipsychotic efficacy.
• To highlight the need for improved models that capture negative and cognitive symptoms.

Main Methods:

• Review of four categories of animal models: developmental, drug-induced, lesion, and genetic manipulation.
• Analysis of behavioral phenotypes, focusing on positive, negative, and cognitive symptoms.
• Examination of rodent tasks with translational relevance to schizophrenia's cognitive domains.

Main Results:

• Most rodent models exhibit 'positive-like' symptoms, reflecting altered dopamine function.
• Fewer models adequately replicate negative symptoms (e.g., social interaction deficits) and cognitive impairments (e.g., learning and memory).
• Limited effectiveness of current antipsychotics on negative and cognitive symptoms in models and patients.

Conclusions:

• There is a critical need for more comprehensive animal models of schizophrenia that better represent negative and cognitive symptoms.
• Developing models that allow assessment of treatments preventing disease development is crucial.
• Further research into neurochemical and structural changes in models will aid the development of more effective therapeutic strategies.